Cargando…
Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide
There presently is no rapid method to assess the bactericidal activity of new regimens for tuberculosis. This study examined PNU-100480, TMC207, PA-824, SQ109, and pyrazinamide, singly and in various combinations, against intracellular M. tuberculosis, using whole blood culture (WBA). The addition o...
Autores principales: | Wallis, Robert S., Jakubiec, Wesley, Mitton-Fry, Mark, Ladutko, Lynn, Campbell, Sheldon, Paige, Darcy, Silvia, Annette, Miller, Paul F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261206/ https://www.ncbi.nlm.nih.gov/pubmed/22279595 http://dx.doi.org/10.1371/journal.pone.0030479 |
Ejemplares similares
-
Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis
por: Wallis, Robert S., et al.
Publicado: (2014) -
In Vivo Efficacy of SQ109 against Leishmania donovani, Trypanosoma spp. and Toxoplasma gondii and In Vitro Activity of SQ109 Metabolites
por: Baek, Kyung-Hwa, et al.
Publicado: (2022) -
Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase
por: Haagsma, Anna C., et al.
Publicado: (2011) -
In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori
por: Makobongo, Morris O., et al.
Publicado: (2013) -
Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
por: Bukhdruker, Sergey, et al.
Publicado: (2020)